Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 224NIH 62NETWORK 51INDUSTRY 24OTHER_GOV 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Lymphoid 2Thoracic 1Sarcoma 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma 2Small Cell Lung Carcinoma 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Hodgkin Disease 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER_GOV × Ifosfamide × Clear all
NCT02324296 2025-06-11

PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases

Azienda USL Reggio Emilia - IRCCS

Completed
46 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02414685 2020-08-07

TIP

National Cancer Institute, Slovakia

Phase 2 Completed
19 enrolled

Neoplasms, Germ Cell and Embryonal

NCT00280878 2016-01-15

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Bayside Health

Phase 2 Completed
12 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

NCT00163761 2016-01-08

Efficacy Study of Outpatient Therapy for Lymphoma

Bayside Health

Phase 2 Completed
90 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00691236 2011-06-23

ZOL

Tata Memorial Hospital

Phase 2/3 Unknown
60 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡